458 related articles for article (PubMed ID: 3962948)
1. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
[TBL] [Abstract][Full Text] [Related]
2. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
3. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
[TBL] [Abstract][Full Text] [Related]
5. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
Chang MH; Hsu HY; Hsu HC; Ni YH; Chen JS; Chen DS
Hepatology; 1995 Nov; 22(5):1387-92. PubMed ID: 7590652
[TBL] [Abstract][Full Text] [Related]
6. The long-term evolution of chronic hepatitis B acquired in childhood.
Manzat Saplacan RM; Mircea PA; Valean SD; Miu N; Burac L; Valean C; Nanulescu M
J Gastrointestin Liver Dis; 2009 Dec; 18(4):433-8. PubMed ID: 20076815
[TBL] [Abstract][Full Text] [Related]
7. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
[TBL] [Abstract][Full Text] [Related]
10. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
Hopkirk N; Moyes CD; Lucas CR
N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
[TBL] [Abstract][Full Text] [Related]
11. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
[TBL] [Abstract][Full Text] [Related]
12. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
13. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive.
Gussetti N; Pornaro E; Largajolli G; D'Elia R
Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers.
Tedder RS; Ijaz S; Gilbert N; Barbara JA; Corden SA; Gilson RJ; Boxall EH
J Med Virol; 2002 Dec; 68(4):505-12. PubMed ID: 12376958
[TBL] [Abstract][Full Text] [Related]
15. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
Koçak N; Ozen H; Yüce A; Gürakan F
Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
[TBL] [Abstract][Full Text] [Related]
18. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
19. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
Jelić D; Jelić O
Acta Med Croatica; 1994; 48(2):77-83. PubMed ID: 7519502
[TBL] [Abstract][Full Text] [Related]
20. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers.
Yap SF; Wong NW; Goh KL
Malays J Pathol; 1994 Jun; 16(1):57-62. PubMed ID: 16329577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
